| Eric Jensen Chou, MD | |
|
11803 Jefferson Ave, Suite 110, Newport News, VA 23606-2565 | |
| (757) 873-0360 | |
| (757) 573-0847 |
| Full Name | Eric Jensen Chou |
|---|---|
| Gender | Male |
| Speciality | Interventional Cardiology |
| Experience | 26 Years |
| Location | 11803 Jefferson Ave, Newport News, Virginia |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1982690772 | NPI | - | NPPES |
| 1982690772 | Medicaid | VA |
| Facility Name | Location | Facility Type |
|---|---|---|
| Riverside Regional Medical Center | Newport news, VA | Hospital |
| Riverside Walter Reed Hospital | Gloucester, VA | Hospital |
| Riverside Doctors' Hospital Of Williamsburg | Williamsburg, VA | Hospital |
| Sentara Williamsburg Regional Medical Center | Williamsburg, VA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Riverside Physician Services Inc | 5092608448 | 743 |
News Archive
Digitalis-based drugs like digoxin have been used for centuries to treat patients with irregular heart rhythms and heart failure and are still in use today.
Tibotec Pharmaceuticals Ltd. has announced the submission of a New Drug Application to the U.S. Food and Drug Administration (FDA) for TMC125 (etravirine), an investigational non- nucleoside reverse transcriptase inhibitor (NNRTI), being studied for use with other antiretroviral (ARV) agents as a treatment for people infected with HIV- 1.
Catapult BioAccel, formerly named CatapultBio, has announced the funding of an Arizona-based early stage firm, Kemeta LLC, a company developing a revolutionary product for application in consumer health and medical markets.
The human body responds to starving conditions, such as famine, to promote the chance of survival. It reduces energy expenditure by stopping heat production and promotes feeding behavior.
› Verified 6 days ago
| Entity Name | Riverside Physician Services Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1194929026 PECOS PAC ID: 5092608448 Enrollment ID: O20040207000400 |
News Archive
Digitalis-based drugs like digoxin have been used for centuries to treat patients with irregular heart rhythms and heart failure and are still in use today.
Tibotec Pharmaceuticals Ltd. has announced the submission of a New Drug Application to the U.S. Food and Drug Administration (FDA) for TMC125 (etravirine), an investigational non- nucleoside reverse transcriptase inhibitor (NNRTI), being studied for use with other antiretroviral (ARV) agents as a treatment for people infected with HIV- 1.
Catapult BioAccel, formerly named CatapultBio, has announced the funding of an Arizona-based early stage firm, Kemeta LLC, a company developing a revolutionary product for application in consumer health and medical markets.
The human body responds to starving conditions, such as famine, to promote the chance of survival. It reduces energy expenditure by stopping heat production and promotes feeding behavior.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Eric Jensen Chou, MD 856 J Clyde Morris Blvd, Suite A, Newport News, VA 23601-1318 Ph: () - | Eric Jensen Chou, MD 11803 Jefferson Ave, Suite 110, Newport News, VA 23606-2565 Ph: (757) 873-0360 |
News Archive
Digitalis-based drugs like digoxin have been used for centuries to treat patients with irregular heart rhythms and heart failure and are still in use today.
Tibotec Pharmaceuticals Ltd. has announced the submission of a New Drug Application to the U.S. Food and Drug Administration (FDA) for TMC125 (etravirine), an investigational non- nucleoside reverse transcriptase inhibitor (NNRTI), being studied for use with other antiretroviral (ARV) agents as a treatment for people infected with HIV- 1.
Catapult BioAccel, formerly named CatapultBio, has announced the funding of an Arizona-based early stage firm, Kemeta LLC, a company developing a revolutionary product for application in consumer health and medical markets.
The human body responds to starving conditions, such as famine, to promote the chance of survival. It reduces energy expenditure by stopping heat production and promotes feeding behavior.
› Verified 6 days ago
Carl Anthony Gibson, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 12200 Warwick Blvd, Suite 590b, Newport News, VA 23601 Phone: 757-534-5909 Fax: 757-534-5911 | |
Dr. Megan Brooke Mcgavern, D.O. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 12652 Jefferson Ave, Newport News, VA 23602 Phone: 757-234-4285 Fax: 757-234-4260 | |
Dr. Ajay S Rathore, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 739 Thimble Shoals Blvd, Newport News, VA 23606 Phone: 757-873-1009 Fax: 757-873-7689 | |
Muhammad Z Rizwan, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 12200 Warwick Blvd Ste 290, Newport News, VA 23601 Phone: 757-534-5454 | |
Dr. Edward S Pak, DO Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 12200 Warwick Blvd Ste 290, Newport News, VA 23601 Phone: 757-534-5454 Fax: 757-534-5491 | |
Dr. Ashutosh Subhash Naniwadekar, MBBS Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 101 Philip Roth St # 5a, Newport News, VA 23606 Phone: 757-599-6333 | |
Dr. Hemchand Ramberan, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 12200 Warwick Blvd Ste 490, Newport News, VA 23601 Phone: 757-599-6333 Fax: 757-591-7261 |